1. Li C, Zhao Z, Zhou J, Liu Y, Wang H, Zhao X*. Relationship between the TERT, TNIP1 and OBFC1 genetic polymorphisms and susceptibility to colorectal cancer in Chinese Han population. Oncobarget,2017,8(34):56932-56941.SCI 收录（IF＝5.168）
2. Wang G, Li J, Zhang L, Huang S, Zhao X, Zhao X*. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway. Biochem Biophys Res Commun. 2017,26;490(3):969-976.SCI 收录（IF＝2.466）
3. Wang G, Yuan N, Huang S, Feng L, Han R, Zhang Y, Ren J, Meng M, Zhao X*.The CNGRCLLII(KLAKLAK)2 peptide shows cytotoxicity against HUVECs by inducing apoptosis: An in vitro and in vivo study.Tumour Biol, 2017,39(5):1010428317701649.SCI 收录（IF＝3.65）
4. Luo M, Huang H, Hou L, Shao S, Huang S, Zhao X*. Construction and expression of a lentivirus expression vector carrying the VEGF165-EGFP fusion gene in breast cancer MCF-7 cells. Oncol Lett, 2017,13(3):1745-1752. SCI 收录（IF＝1.39）
5. Yue C, Li M, Da C, Meng H, Lv S, Zhao X*. Association between genetic variants and esophageal cancer risk.Oncotarget. 2017,8(29):47167-47174. SCI 收录（IF＝5.168）
6. Luo M, Hou L, Li J, Shao S, Huang S, Meng D, Liu L, Feng L, Xia P, Qin T, Zhao X*. VEGF/NRP-1 axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-kB and β-catenin. Cancer Lett,2016,373(1):1-11. SCI收录（IF＝5.992）
7. Li X, Zou W, Liu M, Cao W, Jiang Y, An G, Wang Y, Huang S, Zhao X*. Association of multiple genetic variants with breast cancer susceptibility in the Han Chinese population. Oncotarget, 2016, doi: 10.18632/oncotarget.13402. SCI 收录（IF＝5.008）
8. Wu F, Liu Y, Li J, Hou L, Lei F, Huang S, Feng L, Zhao X*. Human serum albumin-mediated apoptin delivery suppresses breast cancer cell growth in vitro and in vivo. Oncol Lett, 2017, 13(2):579-586. SCI 收录（IF＝1.482）
9. Han R, Wang G, Zhang Y, Zhao X*. Efficacy of neoadjuvant chemotherapy combined with bevacizumab versus neoadjuvant chemotherapy alone for Her2-negative breast cancer: a meta-analysis of randomized controlled clinical trials. Zhejiang Da Xue Xue Bao Yi Xue Ban, 2016, 45(4):379-386. MI 收录
10. Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, Wang Y, Gu S*, Zhao X*. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Mol Cancer, 2015,14:28. SCI收录（IF＝5.888）
11. Wang T, Shigdar S, Gantier MP, Hou Y, Wang L, Li Y, Shamaileh H, Yin W, Zhou SF, Zhao X*, Duan W*. Cancer stem cell targeted therapy: progress amid controversies. Oncotarget, 2015,6(42):44191-206. SCI 收录（IF＝5.008）
12. Zuo X, Chen L, Liu L, Zhang Z, Zhang X, Yu Q, Feng L, Zhao X*, Qin T*. Identification of a panel of complex autoantigens (LGALS3, PHB2, MUC1, and GK2) in combination with CA15-3 for the diagnosis of early-stage breast cancer. Tumor Biol, 2016, 37(1):1309-1317. SCI 收录（IF＝2.926）
13. Zhang X, Zhao X, Shao S, Zuo X, Ning Q, Luo M, Gu S*, Zhao X*. Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role. Int J Oncol, 2015, 46(3):1141-1148. SCI收录（IF＝3.018）
14. Zhang Z, Hou L, Feng L, Huang S, Luo M, Shao S, Zhang X, Gu S, Zhao X*.An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13− tumor cells. Tumor biol, 2015, 36(10):8167-8175. SCI 收录（IF＝2.926）
15. Zhao Y, Yuan NA, Li K, Geng YI, Zhou H, Wang H, Hou J, Zhang B, Cai Y, Zhao X*. Bilateral breast cancer following augmentation mammaplasty with polyacrylamide hydrogel injection: A case report. Oncol Lett,2015, 9(6):2687-2693. SCI 收录（IF＝1.482）
16. Meng D, Liu R, Pei L, Hou L, Ning Q, Yu Q, Feng L, Zhao X*. Lentivirus Vector-mediated Gene Transfection of CNGRC Peptide in Rat Adipose Stem Cells. Mol Med Rep, 2015, 11(4): 2555-2561. SCI 收录（IF＝1.559）
17. Liu L, Hou L, Gu S*, Zuo X, Meng D, Luo M, Zhang X, Huang S, Zhao X*.Molecular mechanism of pigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo. Oncol Rep, 2015, 33(1): 297-303. SCI 收录（IF＝2.486）
18. Wu F, Zhao X, Mi B, Feng Lu, Yuan NA, Lei F, Li M, Zhao X*. Clinical characteristics and prognostic analysis of Krukenberg tumor. Mol Clin Oncol, 2015,3(6):1323-1328.
19. Zuo X, Qin Y, Zhang X, Ning Q, Shao S, Luo M, Yuan N, Huang S, Zhao X*. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI. Oncol Rep, 2014, 31(5): 2358-2364. SCI 收录（IF＝2.486）
20. Yuan N, Meng M, Liu C, Feng L, Hou L, Ning Q, Xin G, Pei L, Gu S*, Li X, Zhao X*. Clinical characteristics and prognostic analysis of triple negative breast cancer patients. Mol Clin Oncol, 2014, 2(2): 245-251.
21. Liu C, Zhao X, Zhao Z, Lu P, Jin F, Li G. Malignant Inflammatory Myofibroblastic Tumor of the Prostate. J Clin Oncol, 2013, 31(10):e144-7. SCI 收录（IF＝20.982）
22. Ning Q, Liu C, Hou L, Meng M, Zhang X, Luo M, Shao S, Zuo X, Zhao X*. Vascular endothelial growth factor receptor-1 activation promotes migration and invasion of breast cancer cells through epithelial-mesenchymal transition. PLoS One,2013, 8(6):e65217. SCI 收录（IF＝3.057）
23. Hou L, Zhao X*, Wang P, Ning Q, Meng M, Liu C. Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells. PLoS One, 2013, 8(1): e53491. SCI 收录（IF＝3.057）
24. Meng M, Zhao X, Dang Y, Ma J, Li L, Gu S*. Region-specific expression of brain-derived neurotrophic factor splice variants in morphine conditioned place preference in mice. Brain Res, 2013, 1519:53-62. SCI 收录（IF＝2.561）
25. Xin G, Zhao X*, Duan X, Ning Q, Meng M, Meng D, Liu L. Antitumor effect of a generation 4 polyamidoamine dendrimer/cyclooxygenase-2 antisense oligodeoxynucleotide complex on breast cancer in vitro and in vivo. Cancer Biother Radiopharm, 2012, 27(1):77-87. SCI 收录（IF＝1.715）
26. Ning Q, Hou L, Meng M, Pan BR, Zhao XH*. TNF related apoptosis -inducing ligand and its receptors in ocular tumors. Int J Ophthalmol, 2011, 4(5):552-557. SCI 收录（IF＝0.939）
27. Wang P, Zhao XH*, Wang ZY, Meng M, Li X, Ning Q. Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment. Cancer Lett, 2010, 298(1):34-49. SCI 收录（IF＝5.992）
28. Meng M, Zhao XH*, Ning Q, Hou L, Xin GH, Liu LF. Tumor stem cells: A new approach for tumor therapy. Oncol Lett, 2012, 4(2): 187-193. SCI 收录（IF＝1.482）
29. Xin GH, Zhao XH*, Liu D, Gong Q, Hou L, Li JY, Pan BR, Li X and Cheng YJ. Effect of VEGF-targeted antisense gene therapy on retinoblastoma cell line SO-RB50 in vitro and in vivo. Int J Ophthalmol, 2012, 5(4): 440-447. SCI 收录（IF＝0.939）
30. Qin TJ, Ma W, Liu SX, Yang GX, Wang QY, Zhao XH*. Secretory expression of Par-4 SAC-HA2TAT following adeno-associated virus-mediated gene transfer induces apoptosis in HepG2 cells. Mol Med Rep, 2010, 3(5):749-757. SCI 收录（IF＝1.559）
31. Gu SZ, Zhao XH*, Zhang LX, Li L, Wang ZY, Meng M, An GL. Anti-angiogenesis effect of generation 4 polyamidoamine/vascular endothelial growth factor antisense oligodeoxynucleotide on breast cancer in vitro. J Zhejiang Univ Sci B, 2009, 10(3):159-167. SCI 收录（IF＝1.303）
32. Qin TJ, Zhao XH*, Yun J, Zhang LX, Ruan ZP, Pan BR. Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma. World J Gastroenterol, 2008, 14(33):5210-5216. SCI 收录（IF＝2.787）
33. Zhao X, Li L, Wang Z. Chemoprevention of breast cancer: current status and future prospects. Front Biosci, 2006, 11:2249-2256. SCI 收录（IF＝2.484）
34. Zhao X, Tian H, Ma X, Li L. Epigallocatechin gallate, the main ingredient of green tea induces apoptosis in breast cancer cells. Front Biosci, 2006, 11:2428-2433. SCI 收录（IF＝2.484）
35. Gu SZ, Zhao XH*, Quan P, Li SB, Pan BR. Alterations of serum cholinesterase in patients with gastric cancer. World J Gastroenterol, 2005, 11(29):4604-4606. MI 收录
36. Zhao XH, Gu SZ, Tian HG, Quan P, Pan BR. Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue. World J Gastroenterol, 2005, 11(25):3846-3849. MI 收录
37. Zhao XH, Gu SZ, Liu SX, Pan BR. Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues. World J Gastroenterol, 2003, 9(4):665-669. SCI 收录（IF＝3.318）
